683 Capital Management, LLC 13F Holdings · Q2 2026
683 Capital Management, LLC reported 126 securities worth $2.04B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: PLTR (13.91%), LLY (9.07%), NVDA (4.48%). Among its top 25 positions this quarter: 2 new, 9 added, 11 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PLTR | PALANTIR TECHNOLOGIES INC | $283.4M | 13.91% | 2.4M | Added |
| 2 | LLY | ELI LILLY & CO | $184.7M | 9.07% | 154,000 | Added |
| 3 | NVDA | NVIDIA CORPORATION | $91.2M | 4.48% | 456,000 | Hold |
| 4 | XBI | SPDR SERIES TRUST | $85.5M | 4.20% | 540,000 | New |
| 5 | COF | CAPITAL ONE FINL CORP | $73.2M | 3.60% | 365,000 | Trimmed |
| 6 | ABBV | ABBVIE INC | $61.7M | 3.03% | 245,000 | New |
| 7 | CVNA | CARVANA CO | $49.4M | 2.42% | 750,000 | Added |
| 8 | MDGL | MADRIGAL PHARMACEUTICALS INC | $48.3M | 2.37% | 90,000 | Hold |
| 9 | ANAB | ANAPTYSBIO INC | $44.6M | 2.19% | 660,000 | Added |
| 10 | ALNY | ALNYLAM PHARMACEUTICALS INC | $42.9M | 2.11% | 142,500 | Trimmed |
| 11 | QURE | UNIQURE NV | $41.0M | 2.02% | 891,200 | Trimmed |
| 12 | KSPI | KASPI KZ JSC | $40.7M | 2.00% | 470,000 | Trimmed |
| 13 | BBIO | BRIDGEBIO PHARMA INC | $38.8M | 1.90% | 0 | Hold |
| 14 | BDX | BECTON DICKINSON & CO | $37.8M | 1.86% | 250,000 | Added |
| 15 | MOH | MOLINA HEALTHCARE INC | $37.7M | 1.85% | 165,000 | Added |
| 16 | PRAX | PRAXIS PRECISION MEDICINES I | $37.0M | 1.82% | 110,400 | Trimmed |
| 17 | HGV | HILTON GRAND VACATIONS INC | $36.1M | 1.77% | 690,000 | Trimmed |
| 18 | PTGX | PROTAGONIST THERAPEUTICS INC | $35.5M | 1.75% | 290,000 | Trimmed |
| 19 | ARKG | ARK ETF TR | $31.5M | 1.55% | 750,000 | Added |
| 20 | MGTX | MEIRAGTX HLDGS PLC | $31.1M | 1.53% | 2.3M | Trimmed |
| 21 | WVE | WAVE LIFE SCIENCES LTD | $28.8M | 1.41% | 5.0M | Added |
| 22 | IONQ | IONQ INC | $25.9M | 1.27% | 486,700 | Trimmed |
| 23 | AMLX | AMYLYX PHARMACEUTICALS INC | $24.7M | 1.21% | 1.4M | Trimmed |
| 24 | AMTM | AMENTUM HOLDINGS INC | $22.7M | 1.12% | 1.1M | Added |
| 25 | TGTX | TG THERAPEUTICS INC | $21.4M | 1.05% | 389,081 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR